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Background: Overweight and obesity prevalence has risen dramatically in recent decades. While it is known that
overweight and obesity is associated with a wide range of chronic diseases, the cumulative burden of chronic
disease in the population associated with overweight and obesity is not well quantified. The aims of this paper
were to examine the associations between BMI and chronic disease prevalence; to calculate Population Attributable
Fractions (PAFs) associated with overweight and obesity; and to estimate the impact of a one unit reduction in
BMI on the population prevalence of chronic disease.
Methods: A cross-sectional analysis of 10,364 adults aged ≥18 years from the Republic of Ireland National Survey
of Lifestyle, Attitudes and Nutrition (SLÁN 2007) was performed. Using binary regression, we examined the
relationship between BMI and the selected chronic diseases. In further analyses, we calculated PAFs of selected
chronic diseases attributable to overweight and obesity and we assessed the impact of a one unit reduction
in BMI on the overall burden of chronic disease.
Results: Overweight and obesity prevalence was higher in men (43.0% and 16.1%) compared to women
(29.2% and 13.4%), respectively. The most prevalent chronic conditions were lower back pain, hypertension, and
raised cholesterol. Prevalence of chronic disease generally increased with increasing BMI. Compared to normal
weight persons, the strongest associations were found in obese women for diabetes (RR 3.9, 95% CI 2.5-6.3),
followed by hypertension (RR 2.9, 95% CI 2.3-3.6); and in obese men for hypertension (RR 2.1, 95% CI 1.6-2.7),
followed by osteoarthritis (RR 2.0, 95% CI 1.2-3.2). Calculated PAFs indicated that a large proportion of chronic
disease is attributable to increased BMI, most noticeably for diabetes in women (42%) and for hypertension in
men (30%). Overall, a one unit decrease in BMI results in 26 and 28 fewer cases of chronic disease per 1,000 men
and women, respectively.
Conclusions: Overweight and obesity are major contributors to the burden of chronic disease in the population.
The achievement of a relatively modest reduction in average BMI in the population has the potential to make a
significant impact on the burden of chronic disease.
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Globally, the prevalence of overweight and obesity has
increased rapidly in recent decades. Global estimates from
2008 show that 1.5 billion adults, 20 years and older, were
overweight, and of these over 200 million men and nearly
300 million women were obese [1]. Projected trends sug-
gest that there will be 65 million more obese adults in the
United States in 2030 than in 2010, and 11 million more
obese adults in the United Kingdom (UK) [2]. Further
projections estimate that by 2035, obesity rates in UK
adults are estimated to rise to 47% for men and 36% for
women, and by 2050, this could rise to 60% for men and
50% for women [3].
Due to these increases, overweight and obesity are
now major contributors to the global burden of disease
[1,4]. Overweight and obesity are the fifth leading risk
for global deaths, resulting in at least 2.8 million adult
deaths each year [1]. Estimates from 2004 indicate that
2.3% (35.8 million) of total global disability-adjusted life
years (DALYs) were attributed to overweight and obesity
[5]. As an increase in the prevalence of overweight and
obesity is expected over the next two decades [6], the
burden of disease associated with overweight and obesity
is likely to increase.
Substantial literature indicates that overweight and obese
individuals have an increased risk of developing a number
of chronic diseases, which can lead to further morbidity
and mortality [7-9], with morbidity having a more pro-
nounced impact [10]. Such chronic diseases include type 2
diabetes, cardiovascular disease (CVD) and cardiovascular
risk factors, respiratory diseases such as asthma, musculo-
skeletal disorders such as osteoarthritis and low back pain,
several cancers, and depression [1,11,12].
The high prevalence of overweight and obesity in Ireland,
36% and 14% respectively [13], based on self-reported data,
is likely to be contributing to an increase in the overall bur-
den of chronic disease. At present, the cumulative burden
of prevalent chronic disease associated with overweight
and obesity is not well quantified. This study aimed to
investigate the burden of chronic disease associated with
overweight and obesity, as defined by Body Mass Index
(BMI) category, in the adult population. The specific objec-
tives of this study were: (i) to describe the prevalence of
overweight, obesity, and chronic disease (ii) to examine the
association between BMI and chronic disease prevalence;
(iii) to calculate Population Attributable Fractions (PAFs)
associated with overweight and obesity; and (iv) to estimate
the impact of a one unit reduction in BMI on the popula-
tion prevalence of chronic disease.
Methods
Ethics statement
SLÁN 2007 was approved by the Research Ethics
Committee of the Royal College of Surgeons of Ireland.This study analysed de-identified, secondary data and was
therefore exempt from Clinical Research Ethics Committee
review.
Study design and covariates
A cross-sectional analysis was conducted using data
from the 2007 Survey of Lifestyle, Attitudes and Nutrition
(SLÁN 2007), the most recent of a series of nationally rep-
resentative health surveys in the Republic of Ireland. The
main component of the SLÁN 2007 survey consisted of
face-to-face interviews conducted with 10,364 randomly
selected participants (response rate 62%). The survey also
included measurements of height, weight, and waist cir-
cumference for 967 respondents aged 18–44 years and a
detailed physical examination of 1,207 respondents aged
45 years and over. Given the small number of respondents
for which measured BMI was collected, self-reported BMI
was considered a better measure to use given the much
larger sample size. Self-reported height and weight were
used to calculate BMI for 9,725 respondents. The popula-
tion for SLÁN 2007 was defined as adults aged 18 years
and over, living in private households in the Republic of
Ireland. The survey consisted of a probabilistic sample in
three stages - geographic area, household and ‘next birth-
day’ participant selection within households. The sample
was drawn from the Geodirectory, a listing of all residen-
tial addresses in Ireland compiled by the postal service.
Further details on study design and sampling can be found
elsewhere [13]. SLÁN 2007 measured socio-demographic
variables including gender, age, highest level of education
attained, marital and employment status, residential loca-
tion, annual household income, and social class. The
social class scheme assigns individuals and households to
social class groups according to occupation and is based
on the European Socio-economic Classification (ESeC)
[14]. The survey also measured lifestyle behaviours in-
cluding diet and nutrition, physical activity, alcohol and
smoking status.
Chronic disease was based on self-reported occur-
rence, based on the question “Have you had any of the
following in the last 12 months?”. Chronic diseases in-
cluded in this analysis were lower back pain, osteoarthritis,
diabetes mellitus, CVD (includes stroke, heart attack,
angina), asthma, bronchitis (includes chronic bronchitis,
chronic obstructive pulmonary disease, emphysema), anx-
iety, and depression. Cardiovascular risk factors included
in the analysis were hypertension and raised cholesterol.
These were based on the question “In the last 12 months,
have you been screened or tested for any of the follow-
ing?”. As the prevalence of stroke, heart attack, and angina
were low, 0.8%, 1.0%, and 2.2% respectively, they were
combined as one variable, CVD, for the analyses. Self-
reported height and weight were used to calculate BMI as
a measure of overweight and obesity. BMI was categorised
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weight 18.5-24.99 kg/m2, overweight 25.0-29.99 kg/m2,
and obese ≥30 kg/m2. Due to the relatively small numbers
involved, the obese category was not further sub-divided
(n = 1,241). The underweight category was excluded from
the analyses due to the small numbers in this category
(n = 182). The following socio-economic and lifestyle
variables were included in the association analysis: age
(18–24; 25–34; 35–44; 45–54; 55–64; and 65+ years),
highest level of education attained (primary; secondary;
third level), social class (classes 1–5, ranging from highest
(class 1 i.e. ESeC 1–2) to lowest (class 4 i.e. ESeC 7–9),
with class 5 as never worked/unclassified/unknown (i.e.
ESeC 10)), employment status (employed; unemployed),
type of smoker (current smoker; former/never smoker),
and frequency of drinking alcohol (never; moderate i.e.
‘monthly or less’ or ‘3 to 4 times a month’; frequent
i.e. ‘2-3 times a week’ or ‘4 or more times a week’).
Statistical analyses
All analyses were carried out using the statistical soft-
ware program Stata, version 12.0 [15]. Sampling weights
were applied to take into account any differences in the
characteristics of the survey sample compared to the
population of interest. BMI was considered both as a
categorical and a continuous variable. Descriptive statis-
tics by BMI category, including age, socio-economic
characteristics and lifestyle behaviours are presented in
Table 1. Statistical significance was defined as P < 0.05.
Univariate analyses were conducted using cross-
tabulation to assess the relationship between the preva-
lence of the various chronic diseases by BMI category.
Percentages were compared using a Chi-square test. To
examine the association between BMI and the selected
chronic diseases, relative risks (RR) and 95% confidence
intervals (CI) were estimated using three log-linear
binary regression models [16] (defined as Model 1,
Model 2, Model 3), using normal weight (BMI 18.5-
24.99 kg/m2) as the reference category. Model 1 was
age-adjusted; Model 2 was adjusted for age, education,
social class, and employment; and Model 3 was adjusted
for age, education, social class, employment, alcohol and
smoking.
To calculate the proportion of risk attributed to over-
weight and obesity, PAFs for the chronic diseases associ-
ated with overweight and obesity were calculated [17,18]
using the ‘punaf ’ command in Stata. PAFs are estimated
from this command using the method recommended by
Greenland and Drescher [19]. Punaf calculates CIs for
the PAF, and also for scenario means and their ratio. For
our ‘ideal’ scenario, overweight and obesity was set to
zero. This identifies the proportion of disease that could
potentially be prevented if overweight and obesity was
eliminated from the population.For each chronic condition, the relative risk associated
with a one kg/m2 reduction in BMI was estimated using
a log-linear binomial regression that included BMI as a
continuous risk factor and adjusted for age, education,
social class, employment, alcohol and smoking. These
relative risks were combined with the prevalence of each
chronic condition to estimate the expected prevalence if
each individual’s BMI was reduced by one unit. The
change in the prevalence indicates the population level
benefit that would be seen for a particular chronic
disease if BMI was reduced by one unit for the entire
population.
When convergence was not achieved using the log-linear
binary model we used a log-linear Poisson model with
‘robust’ estimation variance [20]. Data from participants
with a reported BMI of <10 kg/m2 (n = 14) or >50 kg/m2
(n = 31) were excluded from the analysis in order to
remove outliers.
Results
Socio-demographic and lifestyle factors
Approximately 49% (n = 4,142) of individuals were in the
normal weight category, 36% (n = 3,048) were in the over-
weight category, and 15% (n = 1,241) were in the obese
category (see Table 1). Men were more likely to be over-
weight (43.0% vs 29.2%) or obese (16.1% vs 13.4%) com-
pared to women. The number of men with two or more
chronic conditions increased from 6.9% in the normal
weight category to 8.2% in the overweight category and
11.2% in the obese category. The number of women with
two or more chronic conditions increased from 9.1% in
the normal weight category to 13.0% in the overweight
category and 17.4% in the obese category. Overweight and
obesity was significantly associated with age (P < 0.0001
for both genders). Normal weight people tended to be
younger than those that were overweight or obese. Almost
52% of men and almost 43% of women aged 18–34 years
were in the normal weight category. Overweight and
obesity was highest in 35–44 year old men. In women,
overweight was highest in those aged 65 years and older
while obesity was highest in 45–54 year olds. Normal
weight people tended to be more educated (P < 0.0001 for
both genders). Statistically significant associations were
seen between overweight and obesity and social class
in men (P < 0.0001) and women (P = 0.02). While
overweight people were more likely to be in the high-
est social class group, obese people were more likely
to be in the lowest social class. While overweight and
obesity was associated with higher levels of employ-
ment in men (P = 0.03), it was associated with higher
levels of unemployment in women (P = 0.03). Over-
weight and obese men were less likely to be current
smokers (P < 0.0001), whereas this association was not
seen in women (P = 0.67). While normal weight women
Table 1 Socio-demographic and other selected characteristics, n (%), by BMI category and gender
Males (n = 4,260) Females (n = 4,171)
Normal weight Overweight Obese Normal weight Overweight Obese
All ages 1,745 (41.0) 1,831 (43.0) 684 (16.1) 2,397 (57.5) 1,217 (29.2) 557 (13.4)
No chronic disease 1,272 (73.7) 1,248 (69.4) 446 (66.3) 1,650 (69.7) 777 (64.7) 305 (55.6)
1 chronic disease 335 (19.4) 403 (22.4) 151 (22.5) 503 (21.2) 268 (22.3) 148 (27.0)
2+ chronic diseases 119 (6.9) 147 (8.2) 76 (11.2) 215 (9.1) 156 (13.0) 96 (17.4)
Age (years)
18–24 438 (25.1) 136 (7.4) 25 (3.7) 443 (18.5) 78 (6.4) 45 (8.1)
25–34 464 (26.6) 364 (19.9) 129 (18.8) 577 (24.1) 237 (19.5) 90 (16.2)
35–44 269 (15.4) 408 (22.3) 167 (24.4) 458 (19.1) 218 (18.0) 116 (20.8)
45–54 207 (11.9) 365 (19.9) 149 (21.7) 348 (14.5) 221 (18.1) 135 (24.2)
55–64 159 (9.1) 297 (16.2) 123 (18.0) 223 (9.3) 213 (17.5) 91 (16.4)
65+ 207 (11.9) 262 (14.3) 92 (13.4) 348 (14.5) 249 (20.5) 80 (14.3)
Education level
Primary 254 (14.6) 393 (21.4) 169 (24.7) 346 (14.4) 290 (23.8) 134 (24.1)
Secondary 847 (48.5) 769 (42.0) 328 (48.0) 1018 (42.5) 545 (44.8) 248 (44.5)
Third level 644 (36.9) 669 (36.5) 187 (27.3) 1034 (43.1) 382 (31.4) 175 (31.4)
Social class*
Social class 1 556 (31.9) 723 (39.5) 206 (30.1) 835 (34.8) 357 (29.3) 153 (27.4)
Social class 2 218 (12.5) 248 (13.5) 95 (13.8) 387 (16.1) 203 (16.7) 94 (16.9)
Social class 3 283 (16.2) 340 (18.6) 130 (18.9) 290 (12.1) 159 (13.1) 61 (11.0)
Social class 4 595 (34.1) 478 (26.1) 221 (32.3) 647 (27.0) 352 (28.9) 185 (33.2)
Social class 5 92 (5.3) 42 (2.3) 33 (4.8) 238 (9.9) 146 (12.0) 64 (11.5)
Employment
Employed 1,201 (68.8) 1,351 (73.8) 496 (72.5) 1,250 (52.1) 594 (48.8) 256 (46.0)
Unemployed 544 (31.2) 480 (26.2) 188 (27.5) 1,147 (47.9) 623 (51.2) 301 (54.0)
Smoking status
Current 632 (36.2) 443 (24.2) 180 (26.3) 634 (26.4) 306 (25.2) 138 (24.8)
Former/never 1,113 (63.8) 1,388 (75.8) 504 (73.7) 1,764 (73.6) 911 (74.8) 419 (75.2)
Alcohol intake
Never 246 (14.1) 256 (14.0) 123 (18.0) 494 (20.6) 316 (26.0) 138 (24.8)
Moderate 685 (39.2) 703 (38.4) 277 (40.4) 1,119 (46.7) 544 (44.7) 300 (53.9)
Frequent 815 (46.7) 872 (47.6) 285 (41.6) 784 (32.7) 357 (29.4) 119 (21.3)
Note: All numbers are weighted to account for sampling design; Chronic disease includes lower back pain, osteoarthritis, diabetes, CVD, asthma, bronchitis, anxiety and
depression; *Social class (SC) 1 is highest class, SC 4 is lowest, and SC 5 is never worked/unknown/unclassified; P-values (chi-squared): P < 0.0001 for all variables except
for social class in females (P = 0.02), employment (P = 0.03 for both genders), smoking in females (P = 0.67), and alcohol in males (P = 0.17).
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association was not found in men (P = 0.17).
Gender-specific prevalence of chronic conditions by BMI
category
The most prevalent chronic conditions in both men
and women were lower back pain, hypertension, and
raised cholesterol (Table 2). There was a general trend of
increasing prevalence of chronic disease associated withincreasing BMI. Increasing BMI was associated with
statistically significant increases in the prevalence of lower
back pain, osteoarthritis, diabetes and bronchitis in both
genders. There were also highly significant increases in
the prevalence of hypertension and raised cholesterol
associated with increasing BMI in both genders. Asthma,
anxiety and depression showed a general trend of increas-
ing prevalence associated with increasing BMI but these
were not statistically significant.
Table 2 Prevalence of chronic conditions, n (%), according to BMI category and gender
Males (n = 4,260)‡ Females (n = 4,171)‡
Chronic
condition
Total
prevalence (%)
Normal
weight
Overweight Obese P-value* Total
prevalence (%)
Normal
weight
Overweight Obese P-value*
Lower back pain 16.2 240 (13.8) 313 (17.2) 135 (19.8) 0.010 16.8 341 (14.3) 220 (18.2) 135 (24.3) <0.0001
Osteoarthritis 3.2 34 (1.9) 67 (3.7) 33 (4.8) <0.001 6.2 101 (4.2) 102 (8.5) 54 (9.7) <0.0001
Diabetes 3.1 37 (2.1) 59 (3.3) 33 (4.9) 0.0104 2.8 35 (1.5) 43 (3.6) 38 (6.9) <0.0001
CVD 3.7 63 (3.6) 67 (3.6) 25 (3.6) 0.998 2.4 43 (1.8) 46 (3.7) 11 (2.0) 0.010
Hypertension 16.3 121 (9.6) 260 (18.3) 144 (26.4) <0.0001 16.2 161 (9.1) 217 (22.3) 141 (32.1) <0.0001
Raised
cholesterol 15.5 114 (9.5) 234 (17.8) 123 (23.8) <0.0001 18.3 254 (15.6) 184 (20.2) 102 (24.8) <0.0001
Asthma 5.3 79 (4.6) 103 (5.7) 42 (6.2) 0.290 7.2 173 (7.3) 77 (6.4) 49 (8.9) 0.291
Bronchitis 2.1 24 (1.4) 44 (2.4) 24 (3.5) 0.011 3.1 67 (2.8) 30 (2.5) 33 (5.9) 0.002
Anxiety 4.7 73 (4.2) 91 (5.0) 35 (5.2) 0.553 6.8 148 (6.2) 87 (7.2) 45 (8.1) 0.245
Depression 3.9 69 (4.0) 62 (3.4) 33 (4.9) 0.366 6.4 137 (5.7) 79 (6.6) 48 (8.6) 0.060
Note: ‡ This figure indicates the number of total respondents. As the chronic disease state is not known for all respondents, the actual numbers for each chronic
disease does not sum to this figure. Numbers for men ranged from 4,217 to 4,260 with the exception of hypertension (n = 3,225) and raised cholesterol (n = 3,030), and
for women the numbers ranged from 4,135 to 4,171 with the exception of hypertension (n = 3,195) and raised cholesterol (n = 2,952). *indicates chi-square p- values.
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and BMI category
Table 3 displays the results of the binary regression
model assessing the associations of overweight (BMI
25–29.9 kg/m2) and obesity (BMI ≥30 kg/m2) with the
selected ten chronic conditions among men and women.
As the findings for Models 1, 2 and 3 were very similar;
the results for Model 3 are presented. Statistically signifi-
cant associations were found with increasing BMI and a
number of chronic conditions, after adjusting for poten-
tial confounding factors. A dose–response relationship
was seen for a number of conditions with the strongest
associations found in obese individuals.
There was a positive association between increased
BMI and lower back pain although this association was
statistically significant in obese women only (RR 1.5;Table 3 Multivariable RRs (95% CIs) for selected chronic cond
Chronic
condition
Males (n = 4,260)‡
Overweight Ob
Lower back pain 1.1 (0.9, 1.3) 1.2 (0.
Osteoarthritis 1.5 (1.0, 2.2) 2.0 (1.2
Diabetes 1.1 (0.7, 1.9) 1.6 (0.
CVD 0.8 (0.5, 1.2) 0.7 (0.
Hypertension 1.5 (1.2, 1.9)* 2.1 (1.6
Raised cholesterol 1.3 (1.0, 1.7)* 1.7 (1.3
Asthma 1.3 (1.0, 1.8) 1.5 (1.
Bronchitis 1.5 (0.8, 2.5) 1.9 (1.
Anxiety 1.1 (0.8, 1.7) 1.1 (0.
Depression 0.8 (0.5, 1.2) 1.0 (0.
Note: Figures adjusted for age, education level, social class, employment status, alco
respondents. As the chronic disease state is not known for all respondents, the actu
note in Table 2); *P-value <0.05; **P-value <0.001.95% CI 1.3-1.9). For osteoarthritis, obese men had twice
the risk compared to normal weight men (95% CI 1.2-3.2).
In women, there were positive associations with osteoarth-
ritis for both overweight (RR 1.4; 95% CI 1.0-1.9) and
obesity (RR 1.8; 95% CI 1.2-2.5). For diabetes, although
BMI showed a graded increase, this increase was not
statistically significant in either overweight or obese men
compared to men in the normal weight category. How-
ever, there was a strong statistically significant association
between diabetes and increasing BMI in women. The risk
of diabetes in overweight women was almost twice that of
normal weight women (95% CI 1.1-3.2), and the risk in
the obese category increased almost four- fold compared
to women in the normal weight category (95% CI 2.5-6.3).
For CVD, a positive statistically significant association was
found in overweight women only (RR 1.7; 95% CI 1.0-2.7).itions according to BMI category and gender
Females (n = 4,171)‡
ese Overweight Obese
9, 1.5) 1.2 (1.0, 1.4) 1.5 (1.3, 1.9)**
, 3.2)* 1.4 (1.0, 1.9)* 1.8 (1.2, 2.5)*
9, 2.8) 1.9 (1.1, 3.2)* 3.9 (2.5, 6.3)**
4, 1.2) 1.7 (1.0, 2.7)* 1.0 (0.5, 2.2)
, 2.7)** 1.9 (1.6, 2.3)** 2.9 (2.3, 3.6)**
, 2.3)** 1.1 (0.9, 1.3) 1.3 (1.0, 1.6)*
0, 2.3) 0.9 (0.6, 1.2) 1.3 (0.9, 1.8)
0, 3.5) 0.7 (0.5, 1.1) 1.7 (1.0, 2.9)*
7, 1.7) 1.0 (0.8, 1.4) 1.1 (0.8, 1.5)
6, 1.5) 1.1 (0.8, 1.4) 1.3 (0.9, 1.8)
hol intake and smoking status; ‡ This figure indicates the number of total
al numbers for each chronic disease does not sum to this figure (see similar
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a protective effect against CVD but these were not statisti-
cally significant. Hypertension and raised cholesterol
showed graded and mostly significant associations with
increasing BMI for both genders. These associations were
stronger for hypertension than for raised cholesterol. The
association with hypertension was stronger in women
compared to men both in the overweight (RR 1.9 vs. RR
1.5) and obese (RR 2.9 vs. RR 2.1) groups. Conversely, the
association with raised cholesterol was stronger in men
compared to women both in the overweight (RR 1.3 vs.
1.1) and obese (RR 1.7 vs. 1.3) groups. Asthma showed no
statistically significant associations with increased BMI for
both genders, although the relationship was graded in
men. There was an association between increased BMI
and chronic bronchitis although this was statistically
significant in obese women only (RR 1.7; 95% CI 1.0-2.9).
In both genders, there were no statistically significant
associations found between anxiety and depression and
increasing BMI.
Gender-specific PAFs for selected chronic conditions
attributable to overweight and obesity
Overweight and obesity contribute significantly to the
burden of a number of chronic diseases (Figure 1). Over-
all, the burden of disease associated with overweight and
obesity was higher among women. In women, the largest
burden of disease associated with overweight and obes-
ity, and the proportion of disease that could potentially
be prevented if overweight and obesity was eliminated
from the population includes 42% (95% CI 22%-58%) of
diabetes, 37% (95% CI 29%-45%) of hypertension, 20%
(95% CI 6%-32%) of osteoarthritis, and 11% (95% CI 5%-
18%) of lower back pain. In men, the proportion of disease
that could potentially be prevented if overweight and-30%
-20%
-10%
0%
10%
20%
30%
40%
50%
60%
70%
Lower back pain* Osteoarthritis*** Dia
Men W
Figure 1 Population attributable fractions (%) of selected chronic con
by gender. Note: The vertical lines represent 95% confidence intervals;
***p value < 0.05 for men and women.obesity was eliminated from the population includes 30%
(95% CI 17%-41%) of hypertension, 28% (95% CI 3%-46%)
of osteoarthritis, and 23% (95% CI 8%-35%) of raised
cholesterol. Although increases were seen for diabetes
and lower back pain in men, these were not statistically
significant.
Reduction in prevalence of selected chronic conditions
associated with a one-unit reduction in BMI
Table 4 presents the expected risk reduction for the
selected chronic conditions associated with a one unit
(1 kg/m2) decrease in BMI, stratified by gender and
adjusted for the variables as in Table 3. Overall, by low-
ering BMI by one unit across the population, in analyses
of both genders combined, it is expected that there
would be 28 fewer cases of chronic disease (here chronic
disease includes hypertension, raised cholesterol, lower
back pain, osteoarthritis, diabetes, and asthma) per 1,000
population. Broken down by gender, it is expected that
overall there would be a reduction in chronic disease of
26 (4%) and 28 (4%) cases per 1,000 population for men
and women respectively. The greatest reduction in cases
of chronic disease associated with a population-wide one
unit decrease in BMI was found for hypertension with a
reduction of 11 (7%) and 12 (7%) cases per 1,000 men
and women respectively. This is followed by raised
cholesterol, with a greater reduction expected in men.
Compared to men, there is a greater reduction in cases
of lower back pain, osteoarthritis and diabetes expected
in women, while there is a greater reduction in cases of
asthma expected in men.
Extrapolated to the 2011 Republic of Ireland popula-
tion (CSO 2011 population: Male 18+ years = 1,684,456;
Female 18+ years = 1,745,919) [21], following a one unit
population-wide reduction in BMI, it is expected thatbetes* Hypertension*** Raised cholesterol**
omen
ditions attributable to overweight and obesity (BMI ≥25 kg/m2)
*p value < 0.05 for women only; **p value < 0.05 for men only;
Table 4 Reduction (n,%) per 1,000 population in selected chronic conditions associated with a 1 kg/m2 reduction in BMI
Males Females
Chronic condition Scenario 1a
(n, per 1,000)
Scenario 2b
(n, per 1,000)
Reductionc
n (%)
Scenario 1a
(n, per 1,000)
Scenario 2b
(n, per 1,000)
Reductionc
n (%)
Hypertension 162.6 151.9 10.7 (6.6) 162.4 150.7 11.7 (7.2)
Raised cholesterol 154.9 146.7 8.2 (5.3) 183.3 179.5 3.8 (2.1)
Lower back pain 162.1 159.3 2.8 (1.7) 168.2 162.6 5.6 (3.3)
Osteoarthritis 31.5 30.1 1.4 (4.0) 62 58.9 3.1 (5.0)
Diabetes 30.6 29.5 1.1 (3.6) 28 25.5 2.5 (8.9)
Asthma 52.9 50.9 2.0 (3.8) 72.1 70.6 1.5 (2.1)
Note: aPrevalence of chronic disease based on current BMI levels; bPredicted prevalence of chronic disease based on a one unit (1 kg/m2) reduction in population
BMI, estimated by dividing the prevalence estimates (Scenario 1) by the relative risks obtained from a log-linear regression using BMI as a continuous variable;
cThe reduction in chronic disease prevalence in the population associated with a one unit reduction in BMI.
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disease in men and 49,235 fewer cases of chronic disease
in women. The greatest reduction in cases of disease
associated with a population-wide one unit decrease in
BMI is expected for hypertension with 18,024 fewer
cases in men and 20,427 fewer cases in women.
We also investigated the expected prevalence of over-
weight and obesity associated with a one unit reduction
in BMI. If the population BMI reduced by one unit, the
current prevalence estimates of overweight would reduce
from 43.0% to 37.2% in men and from 29.2% to 23.9% in
women. The current prevalence estimates of obesity would
reduce from 16.1% to 11.6% in men and from 13.4% to
10.2% in women.
Discussion
This study examined the association between over-
weight and obesity and several chronic diseases using
nationally representative survey data from the Republic
of Ireland. It can be concluded from the results that firstly,
there is a high prevalence of overweight and obesity
(BMI ≥25 kg/m2) in Irish adults, particularly among
men (59% vs. 42%). Secondly, overweight and obesity is a
major contributor to a range of chronic diseases and car-
ries a significant disease burden in the Republic of Ireland,
particularly among women. A small reduction in BMI at a
population level would potentially lead to substantial gains
in terms of reduced prevalence of chronic disease.
In this study, hypertension and raised cholesterol in
men, and osteoarthritis, diabetes, CVD, and hyperten-
sion in women were significantly more prevalent in the
overweight category. In the obese category, statistically
significant associations were observed for osteoarthritis,
hypertension, and raised cholesterol in men, and for
lower back pain, osteoarthritis, diabetes, hypertension,
raised cholesterol, and chronic bronchitis in women. As
the RRs generally increased with increasing BMI, this
implies a direct association between increasing BMI and
increasing prevalence of related chronic disease. Previ-
ous cross-sectional studies assessing the overall burdenof chronic disease show similar findings for a number of
conditions [22-25]. Although most of the following did
not reach statistical significance, graded associations
were generally seen for lower back pain, asthma, chronic
bronchitis, anxiety, and depression. Lack of a statistically
significant association between overweight and obesity
and diabetes in men may reflect weight loss following
diagnosis. Similar considerations may apply in relation
to the apparently negative association with CVD, along
with the small number of study participants with this
condition.
The PAFs indicated that a large proportion of a num-
ber of chronic diseases are attributed to overweight and
obesity, suggesting that obesity is an important cause of
morbidity, with a significant impact on health care costs.
A recent report [26] highlighted the substantial direct
and indirect costs associated with overweight and obes-
ity in the Republic of Ireland, with 2009 estimates at
€1.13 billion. Direct healthcare costs accounted for 35%
and indirect costs accounted for 65% of the total costs.
As there is a high level of indirect costs associated with
chronic diseases such as lower back pain and osteoarth-
ritis, and direct costs associated with chronic diseases
such as CVD, reductions in these diseases are likely to
reduce costs incurred with obesity.
As the importance of population-based strategies has
long been recognised [27], a one unit population reduc-
tion in BMI was assessed to estimate the effect such a
strategy may have on the prevalence of chronic disease.
As the prevalence of overweight and obesity is high, and a
considerable proportion of the population are at risk of a
number of chronic diseases, the population approach tar-
geting the entire population is likely to be more effective
and potentially less costly than targeting high-risk individ-
uals, in reducing the prevalence of overweight and obesity
in the population and thus the burden of disease attri-
butable to overweight and obesity. In men, there was a 4%
reduction in chronic disease (reduced from 595 to 568
cases per 1,000 men) associated with a one unit popula-
tion-wide decrease in BMI. In women, there was a 4%
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cases per 1,000 women) associated with a one unit popu-
lation-wide decrease in BMI.
A number of limitations need to be taken into account.
The cross-sectional study design cannot provide evidence
of a temporal relationship or causality. Findings on associ-
ations with individual conditions such as CVD and dia-
betes must be interpreted cautiously given the potential
for reverse causation. Compared to longitudinal studies,
risk estimates are likely to be reduced [24]. Thus, esti-
mates in this study may under-represent the actual risk of
developing a disease. Although the SLÁN 2007 survey had
a reasonable response rate (62%), there is the potential for
selection bias, for example, less healthy individuals may be
more likely to refuse to participate [28], which may have
resulted in an underestimated prevalence of overweight
and obesity and of chronic disease.
The use of self-reported height and weight may have
resulted in reporting bias. Evidence suggests that a con-
siderable number of Irish adults underestimate their
body weight [13], therefore, prevalence estimates in this
study are likely to be underestimated. There may also
have been sex differences in the reporting of height
and weight. While there is a general trend of under-
reporting for weight and over-reporting for height,
the degree of this trend varies for men and women
[29]. One study found that while females tended to
underestimate their weight, males were inclined to
slightly overestimate their weight [30]. A recent study
examining trends in misclassification patterns of mea-
sured and self-reported BMI in the SLÁN surveys did
not find a trend related to gender bias [31], suggest-
ing that the extent of sex differences in the reporting
of BMI in this study is not likely to be considerable.
The use of self-reported chronic conditions may also
have resulted in reporting bias, resulting in an under-
estimation of the true prevalence of chronic disease
and thus an underestimation of the strength of their
association with overweight and obesity. Similar to
the reporting of height and weight, there may also
have been sex differences in the reporting of chronic
conditions; women have been shown to more accurately
self-report diagnoses compared to men [32]. Nonetheless,
it has been found that there is considerable agreement
between medical record diagnosis of disease and patients'
self-reports for a number of chronic diseases [32,33]. The
known association between excess weight and chronic
conditions increases the likelihood of diagnosis in heavier
people and may represent an additional source of bias.
For example, it is likely that diagnosis of high blood
pressure and raised cholesterol is greater in over-
weight and obese individuals due to more frequent mea-
surements in these individuals compared to those that are
of normal weight.The use of BMI as a measure of excess body weight may
lead to some misclassification as it does not distinguish
between fat and muscle mass [13]. The use of other
methods including waist circumference, waist-to-hip ratio,
and skin-fold thickness may provide more accurate
estimates, however, these were not available in the
SLÁN dataset.
It must be noted that for many specific conditions,
such as CVD, the survey produced a relatively small
number of cases, thus possible associations may have
been missed. The findings on individual conditions are
constrained by limited statistical power and random
sampling error. Furthermore, the burden of conditions
with a short natural history for which there are known
associations with overweight and obesity, such as a num-
ber of major cancers, cannot be captured in this type of
study. Therefore, the overall burden of disease associated
with overweight and obesity is underestimated.
Despite these limitations, the current analyses high-
light and quantify the burden of prevalent chronic
disease associated with overweight and obesity and the
findings are similar to other nationally representative
cross-sectional studies [34-36]. The results of this study
are applicable at a population level as a result of apply-
ing sampling weights. A number of important potential
confounding factors were adjusted for in the analyses
and a number of models were employed to assess poten-
tial differences in association depending on the adjust-
ment of certain factors. PAFs, which are useful for
informing public health interventions, were calculated,
although some authors argue that in order to inform
public health interventions, such interventions should be
precisely defined in the estimations [37]. A one unit
reduction in BMI was assessed to strengthen the evi-
dence of the burden of chronic disease associated with
overweight and obesity and the potential decrease in this
burden if overweight and obesity was reduced or elimi-
nated in the population.
Conclusions
The findings of this study support previous observations
of a positive association between overweight and obesity
and a number of chronic diseases. The results highlight
that overweight and obesity are major contributors to
the burden of chronic disease in the Irish population.
Further research in this area will benefit from improved
datasets, data collections methods and study designs.
These efforts will help achieve more reliable compre-
hensive estimates than could be achieved within the
scope of this study. Due to the scale of the problem of
overweight and obesity, population-based strategies for
the prevention of overweight and obesity are urgently
needed. Achieving a relatively modest reduction in aver-
age BMI at the population level is likely to significantly
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and obesity. Further research, focused public health
strategies, and political commitment will likely reduce
the prevalence of overweight and obesity and the burden
of associated disease, resulting in improved population
health and reduced burden on the health service in
the future.
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